Trial intelligence / Profile preview

Intravenous dexmedetomidine versus ketamine for pediatric procedural sedation in the emergency department

IRCT20161226031577N2Phase 3Completed

Sponsor
Vice Chancellor for Research of Mashhad University of Medical Sciences
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of dexmedetomidine and ketamine in Physical trauma (2 arms), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Primary endpoints: Time to sedation onset and Recovery time. Started Mar 2018; status: completed.

02

Drugs

dexmedetomidineketamine
03

Conditions

Physical trauma

Beyond the preview

Go deeper on IRCT20161226031577N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20161226031577N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call